119 related articles for article (PubMed ID: 5723963)
41. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
42. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
Mizejewski GJ; Macario AL
Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
[TBL] [Abstract][Full Text] [Related]
43. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
44. The effect of growth hormone on the development of plasma cell tumor and lymphosarcoma.
Takakura K; Yamada H; Hollander VP
Cancer Res; 1967 Nov; 27(11):2034-41. PubMed ID: 5630408
[No Abstract] [Full Text] [Related]
45. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
Leveille-Webster CR; Arias IA
Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
[TBL] [Abstract][Full Text] [Related]
46. Cell kinetic analysis of human tumor stem cells.
Durie BG; Salmon SE
Prog Clin Biol Res; 1980; 48():153-63. PubMed ID: 7208517
[TBL] [Abstract][Full Text] [Related]
47. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
48. [The kinetics of growth of some transplanted neoplasms in the mouse: S 180, Ca 755, and the ATPC+ ascitic tumor].
Cittadini G; LoCasto Cittadini V; Mancini G; Marchi B
Boll Soc Ital Biol Sper; 1968 Aug; 44(16):1350-4. PubMed ID: 5732790
[No Abstract] [Full Text] [Related]
49. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo.
Valeriote FA; Bruce WR; Meeker BE
J Natl Cancer Inst; 1966 Jan; 36(1):21-7. PubMed ID: 5901524
[No Abstract] [Full Text] [Related]
51. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
Ghanta VK; Hiramoto NS; Hiramoto RN
Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
[TBL] [Abstract][Full Text] [Related]
52. Intra-bone marrow injection of dendritic cells for treatment of malignant tumor in mice.
Koike-Kiriyama N; Koike Y; Adachi Y; Mukaide H; Minamino K; Shigematsu A; Kamiama Y; Matsumura M; Ikehara S
J Exp Clin Cancer Res; 2007 Sep; 26(3):337-42. PubMed ID: 17987792
[TBL] [Abstract][Full Text] [Related]
53. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody.
Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190
[TBL] [Abstract][Full Text] [Related]
54. Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.
Kasuya H; Kuruppu DK; Donahue JM; Choi EW; Kawasaki H; Tanabe KK
Cancer Res; 2005 May; 65(9):3823-7. PubMed ID: 15867380
[TBL] [Abstract][Full Text] [Related]
55. [Experimental plasmacytoma of the mouse: immunofluorescence studies].
Del Giacco GS; Fantini F; Invernizzi F
Riv Ist Sieroter Ital; 1967; 42(5):228-30. PubMed ID: 4879432
[No Abstract] [Full Text] [Related]
56. Antimestatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: Orthotopic growth in severe combined immunodeficient mice.
Stearns ME; Wang M
Clin Cancer Res; 1998 Sep; 4(9):2257-63. PubMed ID: 9748147
[TBL] [Abstract][Full Text] [Related]
57. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
[TBL] [Abstract][Full Text] [Related]
58. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
Olsson L; Kiger N; Kronstrom H
Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
[TBL] [Abstract][Full Text] [Related]
59. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
Maestroni GJ; Covacci V; Conti A
Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
[TBL] [Abstract][Full Text] [Related]
60. Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
Rico-Vargas SA; Potter M; Osmond DG
J Immunol; 1995 Mar; 154(5):2082-91. PubMed ID: 7868885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
